Background:Retention in care and treatment services is critical to health outcomes of individuals diagnosed and living with HIV. We evaluated the incidence of and risk factors for treatment discontinuation (TD) in a large adult HIV population on ART in Nigeria.Method:A retrospective cohort study of adult HIV patients initiated on first-line ART between 2004 and 2011 at the Jos University Teaching Hospital (JUTH) in Nigeria. Follow up information of participants was retrieved from various sources (patient visit database, pharmacy data and patients charts) up to the end of 2012.The primary study endpoint was TD, defined as discontinuation of ART for any reason, including death or loss to follow-up (lack of pharmacy pick-up for periods 6512 m...
OBJECTIVES: We assessed retention and predictors of attrition (recorded death or loss to follow-up) ...
Background: Most evaluations of loss to follow-up (LTFU) in human immunodeficiency virus (HIV) treat...
BACKGROUND:The Nigerian Antiretroviral therapy (ART) program started in 2004 and now ranks among the...
BACKGROUND: Understanding the correlates of disengagement from HIV care and treatment failure during...
Background: Unplanned care interruption (UCI) challenges effective HIV treatment. We determined the ...
Background: Considerable success has been recorded in the global fight against the human immunodefic...
With about 3.4 million HIV-infected persons, Nigeria has the second highest number of people living ...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
Introduction: Poor retention of patients in care is a major driver of poor performance and increased...
It is well acknowledged that antiretroviral therapy (ART) discontinuation hampers the progress towar...
BackgroundContinuous antiretroviral therapy (ART) is important for maintaining viral suppression. Th...
BACKGROUND : Patient interruption of antiretroviral therapy (ART) continues to limit HIV programs’ p...
To evaluate the rate and factors associated with attrition of patients receiving ART in tertiary and...
Published: January 20, 2017BACKGROUND: Discontinuation of antiretroviral therapy (ART) reduces the i...
To evaluate the rate and factors associated with attrition of patients receiving ART in tertiary and...
OBJECTIVES: We assessed retention and predictors of attrition (recorded death or loss to follow-up) ...
Background: Most evaluations of loss to follow-up (LTFU) in human immunodeficiency virus (HIV) treat...
BACKGROUND:The Nigerian Antiretroviral therapy (ART) program started in 2004 and now ranks among the...
BACKGROUND: Understanding the correlates of disengagement from HIV care and treatment failure during...
Background: Unplanned care interruption (UCI) challenges effective HIV treatment. We determined the ...
Background: Considerable success has been recorded in the global fight against the human immunodefic...
With about 3.4 million HIV-infected persons, Nigeria has the second highest number of people living ...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
Introduction: Poor retention of patients in care is a major driver of poor performance and increased...
It is well acknowledged that antiretroviral therapy (ART) discontinuation hampers the progress towar...
BackgroundContinuous antiretroviral therapy (ART) is important for maintaining viral suppression. Th...
BACKGROUND : Patient interruption of antiretroviral therapy (ART) continues to limit HIV programs’ p...
To evaluate the rate and factors associated with attrition of patients receiving ART in tertiary and...
Published: January 20, 2017BACKGROUND: Discontinuation of antiretroviral therapy (ART) reduces the i...
To evaluate the rate and factors associated with attrition of patients receiving ART in tertiary and...
OBJECTIVES: We assessed retention and predictors of attrition (recorded death or loss to follow-up) ...
Background: Most evaluations of loss to follow-up (LTFU) in human immunodeficiency virus (HIV) treat...
BACKGROUND:The Nigerian Antiretroviral therapy (ART) program started in 2004 and now ranks among the...